Hui‐Min Lin
Blueprint Medicines (United States)(US)
Publications by Year
Research Areas
Mast cells and histamine, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Advanced Causal Inference Techniques, Statistical Methods in Clinical Trials
Most-Cited Works
- → Importance of glycolysis and oxidative phosphorylation in advanced melanoma(2012)166 cited
- → Meta-analysis methods for combining multiple expression profiles: comparisons, statistical characterization and an application guideline(2013)138 cited
- → Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer(2016)87 cited
- → The clinical anti‐aging effects of topical kinetin and niacinamide in Asians: a randomized, double‐blind, placebo‐controlled, split‐face comparative trial(2007)70 cited
- → Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab(2016)26 cited
- → Correct and logical inference on efficacy in subgroups and their mixture for binary outcomes(2018)23 cited
- → Subgroup mixable inference on treatment efficacy in mixture populations, with an application to time‐to‐event outcomes(2015)23 cited
- → Statistics for X‐chromosome associations(2018)21 cited
- → A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma(2017)7 cited
- → Abstract B20: Prediction of lung cancer survival by genes in the PAM50 breast cancer panel.(2014)3 cited